| Market revenue in 2025 | USD 108.8 million |
| Market revenue in 2033 | USD 238.8 million |
| Growth rate | 10.13% (CAGR from 2026 to 2033) |
| Largest segment | Variant calling and annotation |
| Fastest growing segment | Data Preprocessing and Quality Control |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Data Preprocessing and Quality Control, Variant Calling and Annotation, Gene Expression Analysis, Data Interpretation and Reporting, Other Service Type |
| Key market players worldwide | Illumina Inc, Qiagen NV, CD Genomics, Arsenal Capital Partners, Charles River Laboratories International Inc, BGI Group, Fios Genomics, Eurofins Scientific, Basepair, Golden Helix, Inc. |
Publish Date: Jul 01, 2026
Last Updated: Aug 26, 2026
No credit card required*
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Illumina Inc | View profile | 9,300 | 5200 Illumina Way, San Diego, CA, United States, 92122 | www.illumina.com |
| Qiagen NV | View profile | 5,900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | www.qiagen.com |
| Charles River Laboratories International Inc | View profile | 21,400 | 251 Ballardvale Street, Wilmington, MA, United States, 01887 | www.criver.com |
| Fios Genomics | View profile | 11-50 | Edinburgh, Edinburgh, City of, United Kingdom, Europe | www.fiosgenomics.com/ |
| BGI Group | View profile | 5001-10000 | Shenzhen, Guangdong, China, Asia | www.genomics.cn/ |
| Arsenal Capital Partners | View profile | 101-250 | New York, New York, United States, North America | arsenalcapital.com |
| CD Genomics | View profile | 51-100 | Shirley, New York, United States, North America | www.cd-genomics.com |
| Golden Helix, Inc. | View profile | - | - | - |
| Eurofins Scientific | View profile | - | - | - |
| Basepair | View profile | 1-10 | New York, New York, United States, North America | www.basepairtech.com |
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Genomics Data Analysis Market Outlook will help companies and investors design strategic landscapes.
Variant Calling And Annotation was the largest segment with a revenue share of 35.57% in 2025.
Horizon Databook has segmented the Australia genomics data analysis market based on data preprocessing and quality control, variant calling and annotation, gene expression analysis, data interpretation and reporting, other service type covering the revenue growth of each sub-segment from 2021 to 2033.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia Genomics Data Analysis Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Australia Genomics Data Analysis Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
